Moderna has announced plans to seek emergency authorization for its COVID-19 vaccine after data showed it to be 94.1 percent effective.
The company said it will apply for emergency use authorization from the Food and Drug Administration for its COVID-19 vaccine on Monday. This announcement comes after Moderna earlier this month revealed that preliminary phase-three trial data showed its vaccine candidate was almost 95 percent effective.
On Monday, Moderna said an analysis of 196 cases "confirms the high efficacy observed at the first interim analysis," and additionally, data also showed the vaccine was 100 percent effective at preventing severe COVID-19 cases.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Moderna is the second company to seek emergency authorization for a vaccine against COVID-19. Pfizer previously announced it would also be submitting a request for FDA emergency authorization for its vaccine candidate, which data showed was about 95 percent effective.
When COVID-19 vaccines begin to roll out, those at the highest risk are expected to receive them first. Moderna CEO Stéphane Bancel told The New York Times that should the company's vaccine receive emergency approval, the first doses could potentially be given by Dec. 21, and the company expects to produce 20 million doses in the United States by the end of the year.
-
The Icelandic women’s strike 50 years onIn The Spotlight The nation is ‘still no paradise’ for women, say campaigners
-
Mall World: why are people dreaming about a shopping centre?Under The Radar Thousands of strangers are dreaming about the same thing and no one sure why
-
Why scientists are attempting nuclear fusionThe Explainer Harnessing the reaction that powers the stars could offer a potentially unlimited source of carbon-free energy, and the race is hotting up
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
